Peptidoglycan Biogenesis in Escherichia Coli
Peptidoglycan Biogenesis in Escherichia Coli
批准号:
9884258
负责人:
Thomas G Bernhardt
金额:
$53.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-01 至 2024-12-31
关键词:
ActinsAddressAnti-Bacterial AgentsAntibioticsAreaBacillusBacteriaBiochemicalBiochemical GeneticsBiogenesisBiologicalCell ShapeCell WallCell divisionCell membraneCell modelCell physiologyCellsCellular biologyCollectionComplexCoupledCuesCytolysisCytoskeletonDevelopmentDrug resistanceEnzymesEscherichia coliFoundationsGeneticGenetic studyGoalsGram-Negative BacteriaGrowthHealthHumanHyperactive behaviorInfectionKnowledgeLearningMembrane ProteinsMethodsMicrofilamentsMolecularMonitorMorphogenesisOrganismPathway interactionsPenicillin-Binding ProteinsPenicillinsPeptidesPeptidoglycanPharmaceutical PreparationsPhysiologicalPolymerasePolysaccharidesProcessProtein FamilyProteinsPseudomonas aeruginosaResearch ProposalsRodRoleShapesStructureSystemTubulinVancomycinVariantWorkcell envelopecell growthcombatcrosslinkdaughter cellexperimental studygenetic analysisin vitro activitymutantnovelpreventprotein functionresponseskillssynthetic enzymetargeted agent
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
A major goal of bacterial cell biology is to understand the mechanisms underlying the assembly and growth of
the cell envelope. In addition to addressing a fundamental biological question, studies in this area have
significant consequences for human health. The envelope serves as both a major target for antibiotics and, in
the case of gram-negative bacteria, a formidable barrier that prevents drugs from reaching their target. Thus,
understanding of the mechanisms required for construction of the gram-negative envelope will help identify
new vulnerabilities in the process to target for antibiotic development. The peptidoglycan (PG) cell wall layer of
the envelope is critical for cell shape and integrity. It is composed of long glycans connected by crosslinks
between attached peptides to form a net-like structure that surrounds and protects the cytoplasmic membrane
from osmotic lysis. In E. coli and many other bacilli, the processes of cell elongation and cell division are
carried out by multi-protein cell wall synthetic machines called the Rod system and the divisome, respectively.
The Rod system is organized by filaments of the actin-like protein MreB whereas the tubulin-like protein FtsZ
governs cell division. Despite years of study, the function of proteins within these machineries have remained
surprisingly ill-defined. Until recently, it has even been unclear which enzymes synthesize PG within these
complexes. Because they were the only factors known to possess PG glycan polymerase activity, the class A
penicillin-binding proteins (aPBPs) have traditionally been thought to fill this role. However, we changed this
view by demonstrating that SEDS (shape, elongation, division, and sporulation) proteins in the Rod system
(RodA) and divisome (FtsW) have PG polymerase activity and work in conjunction with PG crosslinking
enzymes called class B PBPs (bPBPs) to build the cell wall. Our findings have therefore led us to propose a
new model for cell wall synthesis where SEDS-bPBP complexes form the core PG synthases of cytoskeletally
organized machineries, with RodA-PBP2 and FtsW-PBP3 comprising the Rod system and divisome synthases,
respectively. The experiments described in this proposal will build on our recent breakthrough by taking
advantage of a newly developed genetic system for the isolation of mutants encoding inactive or hyperactive
Rod systems. Several mutants isolated provide a foundation for defining how RodA polymerase activity is
regulated within the Rod system and coupled with the crosslinking activity of PBP2. Additional genetic
analyses will also be initiated aimed at defining the function of other conserved yet poorly characterized
components of the Rod system and their potential role in regulating the activity of the core RodA-PBP2
synthase. Finally, biochemical and genetic studies will be initiated to understand how the related FtsW-PBP3
synthase is regulated within the divisome. Overall, the results will significantly advance our understanding of
cell wall biogenesis by multi-protein PG synthetic machineries, and the knowledge gained will aid the discovery
of new classes of antibacterial agents that target these systems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3: Defining and defeating the mechanisms of outer membrane biogenesis in Gram-negative bacteria
-
批准号:10699956
-
项目类别:
-
资助金额:$87.6万
-
财政年份:2022
-
负责人:Thomas G Bernhardt
-
依托单位:
2017 Boston Bacterial Meeting (BBM)
-
批准号:9331190
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2017
-
负责人:Thomas G Bernhardt
-
依托单位:
Targeting cell separation systems of gram-negative bacteria.
-
批准号:8807923
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2014
-
负责人:Thomas G Bernhardt
-
依托单位:
Targeting cell separation systems of gram-negative bacteria.
-
批准号:9238648
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2014
-
负责人:Thomas G Bernhardt
-
依托单位:
Targeting cell separation systems of gram-negative bacteria.
-
批准号:8703851
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2014
-
负责人:Thomas G Bernhardt
-
依托单位:
Identifying and validating new antibiotic targets in cell wall synthesis pathways
-
批准号:8843345
-
项目类别:
-
资助金额:$85.88万
-
财政年份:2012
-
负责人:Thomas G Bernhardt
-
依托单位:
Identifying and validating new antibiotic targets in cell wall synthesis pathways
-
批准号:9067422
-
项目类别:
-
资助金额:$85.88万
-
财政年份:2012
-
负责人:Thomas G Bernhardt
-
依托单位:
Identifying and validating new antibiotic targets in cell wall synthesis pathways
-
批准号:8279957
-
项目类别:
-
资助金额:$93.63万
-
财政年份:2012
-
负责人:Thomas G Bernhardt
-
依托单位:
Identifying and validating new antibiotic targets in cell wall synthesis pathways
-
批准号:8659341
-
项目类别:
-
资助金额:$85.88万
-
财政年份:2012
-
负责人:Thomas G Bernhardt
-
依托单位:
Identifying and validating new antibiotic targets in cell wall synthesis pathways
-
批准号:8475545
-
项目类别:
-
资助金额:$80.71万
-
财政年份:2012
-
负责人:Thomas G Bernhardt
-
依托单位:
Peptidoglycan Biogenesis in Escherichia Coli
-
批准号:8602803
-
项目类别:
-
资助金额:$41.34万
-
财政年份:2010
-
负责人:Thomas G Bernhardt
-
依托单位:
Peptidoglycan Biogenesis in Escherichia Coli
-
批准号:10317080
-
项目类别:
-
资助金额:$53.5万
-
财政年份:2010
-
负责人:Thomas G Bernhardt
-
依托单位:
Peptidoglycan Biogenesis in Escherichia Coli
-
批准号:9194374
-
项目类别:
-
资助金额:$48.26万
-
财政年份:2010
-
负责人:Thomas G Bernhardt
-
依托单位:
Peptidoglycan Biogenesis in Escherichia Coli
-
批准号:8815765
-
项目类别:
-
资助金额:$44.7万
-
财政年份:2010
-
负责人:Thomas G Bernhardt
-
依托单位:
Peptidoglycan Biogenesis in Escherichia Coli
-
批准号:8415565
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2010
-
负责人:Thomas G Bernhardt
-
依托单位:
Peptidoglycan Biogenesis in Escherichia Coli
-
批准号:8967553
-
项目类别:
-
资助金额:$44.7万
-
财政年份:2010
-
负责人:Thomas G Bernhardt
-
依托单位:
Peptidoglycan Biogenesis in Escherichia Coli
-
批准号:8010836
-
项目类别:
-
资助金额:$41.39万
-
财政年份:2010
-
负责人:Thomas G Bernhardt
-
依托单位:
Peptidoglycan Biogenesis in Escherichia Coli
-
批准号:7791155
-
项目类别:
-
资助金额:$42.17万
-
财政年份:2010
-
负责人:Thomas G Bernhardt
-
依托单位:
Peptidoglycan Biogenesis in Escherichia Coli
-
批准号:10554246
-
项目类别:
-
资助金额:$53.5万
-
财政年份:2010
-
负责人:Thomas G Bernhardt
-
依托单位:
Peptidoglycan Biogenesis in Escherichia Coli
-
批准号:8204857
-
项目类别:
-
资助金额:$41.37万
-
财政年份:2010
-
负责人:Thomas G Bernhardt
-
依托单位:
海外基金